Erucamide
|
Basic information |
| Metabolite name | Erucamide |
 | N/A |
 |
N/A |
 |
5365371 |
| Synonyms | 13Z-Docosenamide |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Erucamide |
| N/A |
|
N/A |
|
5365371 |
| Synonyms | 13Z-Docosenamide |
| No. of studies | 4 |
|
Relationship between Erucamide and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M689 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M689 | Type2 | CUMS + Danzhi Xiaoyao Powder group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Hippocampus | BALB/c mouse | Up |
| Study M951 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M951 | Type2 | CUMS + paeoniflorin group vs. CUMS group | Urine | Sprague-Dawley rat | Up |